S. Hogg

Escitalopram, the S-(+)-enantiomer of citalopram, is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytic activities

Connie Sánchez, Peter B. F. Bergqvist, Lise T. Brennum et al. · Psychopharmacology · 2003 · 265 citations

Psychiatry, Medicine, Psychotropic Medication +11

Pharmacological Effects of Lu AA21004: A Novel Multimodal Compound for the Treatment of Major Depressive Disorder

Arne Mørk, Alan L. Pehrson, Lise T. Brennum et al. · Journal of Pharmacology and Experimental Therapeutics · 2011 · 265 citations

Differential Effects of Acute and Chronic Social Defeat Stress on Hypothalamic‐Pituitary‐Adrenal Axis Function and Hippocampal Serotonin Release in Mice

Adam J. Keeney, D. S. Jessop, Michael S. Harbuz et al. · Journal of Neuroendocrinology · 2006 · 254 citations

Neuroendocrinology, Hypothalamic Circuits, Hypothalamic‐pituitary‐adrenal Axis Function +23

Behavioural consequences of repeated social defeat in the mouse: preliminary evaluation of a potential animal model of depression

Adam J. Keeney, S. Hogg · Behavioural Pharmacology · 1999 · 143 citations

Monitoring enzyme replacement therapy in Fabry disease—Role of urine globotriaosylceramide

Phillip D. Whitfield, J Calvin, S. Hogg et al. · Journal of Inherited Metabolic Disease · 2005 · 90 citations